← All companies

HELP

Cybin D/B/A Helus Pharma

HELP Nasdaq Pharmaceutical Preparations EDGAR ↗

$8.06

-0.08 -0.98%

Key statistics

from XBRL data in SEC filings

Market cap

$174M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$3.76 – $9.12

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Aug 3, 2026 6-K Jul 21, 2026 6-K FORM 6-K Jul 16, 2026 6-K Jun 29, 2026 40-F Jun 29, 2026 6-K Jun 25, 2026 6-K FORM 6-K Jun 25, 2026 6-K Jun 11, 2026 6-K Jun 1, 2026 6-K May 4, 2026 6-K Apr 30, 2026 6-K Apr 28, 2026 6-K Apr 23, 2026 6-K Apr 20, 2026 6-K Apr 20, 2026 6-K Apr 16, 2026 6-K Mar 12, 2026 6-K FORM 6-K Mar 5, 2026 6-K FORM 6-K Mar 5, 2026 6-K Feb 24, 2026 6-K Feb 18, 2026 6-K Feb 17, 2026 6-K Feb 13, 2026 6-K Feb 10, 2026 6-K Jan 5, 2026 6-K FORM 6-K Dec 31, 2025 6-K FORM 6-K Dec 30, 2025 6-K Dec 22, 2025 6-K Dec 18, 2025 6-K Nov 26, 2025 6-K Nov 13, 2025 6-K Nov 12, 2025 6-K Nov 6, 2025 6-K Nov 5, 2025 6-K Nov 3, 2025 6-K Oct 31, 2025 6-K FORM 6-K Oct 29, 2025 6-K Oct 28, 2025 6-K Sep 23, 2025 6-K FORM 6-K Sep 18, 2025